Growth Stocks To Research – May 16th

Novo Nordisk A/S, ACADIA Pharmaceuticals, and Blackstone are the three Growth stocks to watch today, according to MarketBeat’s stock screener tool. Growth stocks are shares of companies expected to achieve above-average revenue and earnings growth over time. These firms typically reinvest profits back into the business rather than pay out dividends, driving valuations based on future potential. Investors in growth stocks seek capital appreciation, though they often face higher price volatility. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

NYSE NVO traded down $2.04 on Friday, reaching $64.11. The company had a trading volume of 13,385,364 shares, compared to its average volume of 6,526,772. The company has a quick ratio of 0.55, a current ratio of 0.74 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $287.68 billion, a PE ratio of 19.48, a price-to-earnings-growth ratio of 0.90 and a beta of 0.65. The firm’s 50 day moving average price is $67.59 and its 200 day moving average price is $84.91. Novo Nordisk A/S has a 12 month low of $57.00 and a 12 month high of $148.15.

ACADIA Pharmaceuticals (ACAD)

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases in the United States. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 for treatment of Rett Syndrome.

Shares of ACADIA Pharmaceuticals stock traded up $4.70 during trading hours on Friday, reaching $22.30. The company’s stock had a trading volume of 14,460,540 shares, compared to its average volume of 1,903,189. The firm has a 50 day moving average price of $15.81 and a 200-day moving average price of $17.02. ACADIA Pharmaceuticals has a one year low of $13.40 and a one year high of $25.06. The stock has a market cap of $3.73 billion, a P/E ratio of 28.64 and a beta of 0.47.

Blackstone (BX)

Blackstone Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies. The firm typically invests in early-stage companies. It also provide capital markets services.

Shares of BX stock traded up $0.21 during trading hours on Friday, reaching $146.96. 1,618,099 shares of the stock were exchanged, compared to its average volume of 3,768,479. Blackstone has a 12-month low of $115.66 and a 12-month high of $200.96. The company has a current ratio of 0.67, a quick ratio of 0.71 and a debt-to-equity ratio of 0.61. The company’s 50-day moving average price is $137.08 and its 200-day moving average price is $161.71. The firm has a market capitalization of $107.23 billion, a price-to-earnings ratio of 40.50, a price-to-earnings-growth ratio of 1.07 and a beta of 1.67.